Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | P12 - Poster Session 12

Tuesday 04/05/22
05:30 PM - 06:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Education, Research, and Methodology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT Abstract 9-001 - Acute Hemorrhagic Leukoencephalitis as a Primary Presentation in an Immunocompromised Patient With Cerebral Toxoplasmosis
Sukriye Damla Kara, MD
05:30 PM - 06:30 PM PDT Abstract 9-002 - A case report of Granulomatous angiitis associated with Cogan syndrome.
Praveen Ramani, MBBS
05:30 PM - 06:30 PM PDT Abstract 9-003 - HSV-2 Encephalitis Presenting with Immune-Responsive Chorea
Michael Dmitriy Kolesnik, DO
05:30 PM - 06:30 PM PDT Abstract 9-004 - NMDAR-Antibody Encephalitis Presenting with Faciobrachial Dystonic Seizues in a Gravid Nigerian Woman
Fatima Ilemona Abdulai, MBBS
05:30 PM - 06:30 PM PDT Abstract 9-006 - Spectrum of Combined Central and Peripheral Demyelination: A Case Report
Sukriye Damla Kara, MD
05:30 PM - 06:30 PM PDT Abstract 9-007 - Pediatric AMPA Receptor Encephalitis (AMPARE): A Case Report and Literature Review
Alexandra Estelle Sankovic, MD
05:30 PM - 06:30 PM PDT Abstract 15-001 - Real-World Effectiveness of Ubrogepant Among Participants With Prior Treatment Failure: Subgroup Analysis From the UNIVERSE Study
Krutika Jariwala-Parikh, PhD
05:30 PM - 06:30 PM PDT Abstract 15-002 - Reductions in Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis
Verena *use 212969 Ramirez Campos, MD
05:30 PM - 06:30 PM PDT Abstract 15-003 - Reduction in Period Prevalence of Medication Overuse Headache Following Initiation of Nurtec ODT Treatment – A Real World Administrative Claims Study
Ali Mohajer, PhD
05:30 PM - 06:30 PM PDT Abstract 15-004 - Early Prediction of Response to INP104 for the Acute Treatment of Migraine
Sara E. Sacco, MD
05:30 PM - 06:30 PM PDT Abstract 15-005 - Efficacy and Safety of Subcutaneous Sumatriptan for Acute Migraine Attacks Compared with other treatments: A Systematic Review and Network Meta-analysis.
Mohamed Sayed Zaazouee
05:30 PM - 06:30 PM PDT Abstract 3-001 - Functional Connectivity Rearrangements Propagating from Disease Epicenters in Frontotemporal Lobar Degeneration Variants
Edoardo G. Spinelli, MD
05:30 PM - 06:30 PM PDT Abstract 3-002 - Neuroinflammation biomarker in non-fluent/agrammatic variant of primary progressive aphasia and/or apraxia of speech
Belen Pascual, PhD
05:30 PM - 06:30 PM PDT Abstract 3-003 - Active elite rugby participation predicts alterations in right precentral cortical thickness
Thomas David Parker, PhD, BMBCh, MRCP
05:30 PM - 06:30 PM PDT Abstract 3-004 - White Matter Hyperintensity on Cholinergic Pathways is Associated with Dementia Severity in e4 Carriers, not in Non-carriers
Tracy Ming-Chun Yu, MD
05:30 PM - 06:30 PM PDT Abstract 3-005 - Neuronal intranuclear inclusion disease (NIID) showing positive results on Pittsburgh Compound-B PET imaging
Pu-Tien Chiang, MD
05:30 PM - 06:30 PM PDT Abstract 12-001 - Neurological Disease Burden in Females with X-linked Adrenoleukodystrophy
Natalie Grant
05:30 PM - 06:30 PM PDT Abstract 12-002 - Imaging Features of Adult-Onset Genetic Leukodystrophies Misdiagnosed as Multiple Sclerosis in Clinical Practice
Alise Kathryn Carlson, MD
05:30 PM - 06:30 PM PDT Abstract 12-003 - Real-world Comparative Effectiveness and Persistence of Cladribine Tablets and Other Oral Disease-Modifying Treatments for Multiple Sclerosis from GLIMPSE: Results from the MSBase Registry
Elisabetta Verdun Di Cantogno, MD
05:30 PM - 06:30 PM PDT Abstract 12-004 - A retrospective evaluation of people with Multiple Sclerosis, to determine factors predicting who declines Disease Modifying Therapies
Thomas Jackson
05:30 PM - 06:30 PM PDT Abstract 12-005 - Outcomes and prognostic factors in myelopathies
Maria Alejandra Garcia-Dominguez, MD
05:30 PM - 06:30 PM PDT Abstract 12-006 - Knowledge, skills, and confidence of healthcare professionals participating in the ECHO MS program
Kevin Alschuler
05:30 PM - 06:30 PM PDT Abstract 12-007 - Regional Atrophy of the Thalamus as a Biomarker for Progressive Multiple Sclerosis
Showly Nicholson
05:30 PM - 06:30 PM PDT Abstract 12-008 - Choroid plexus enlargement in multiple sclerosis is associated with decreased brain volume
Niels Bergsland
05:30 PM - 06:30 PM PDT Abstract 12-009 - DeepGRAI (Deep Gray Rating via Artificial Intelligence) Provides Feasible and Clinically Meaningful Thalamic Volume Measurement on Multi-Center Clinical-Quality T2-FLAIR Images
Robert Zivadinov, MD, PhD, FAAN
05:30 PM - 06:30 PM PDT Abstract 12-010 - White Matter Binding in PET: Pittsburgh Compound-B and Flutemetamol
Burcu Zeydan, MD
05:30 PM - 06:30 PM PDT Abstract 12-011 - Brain Network Centrality Abnormalities Underpin Multiple Sclerosis Disease Course
Antonio Carotenuto
05:30 PM - 06:30 PM PDT Abstract 6-001 - Intractable Epilepsy and Ischemic Strokes in Two Children, both with CACNA1A Gene Mutations
Kristen Bolte
05:30 PM - 06:30 PM PDT Abstract 6-002 - Hemiconvulsion-Hemiplegia-Epilepsy Syndrome in the Setting of COVID-19 Infection and Multisystem Inflammatory Syndrome in Children
Paul Gong, MD
05:30 PM - 06:30 PM PDT Abstract 6-003 - Successful remission with ACTH after early therapeutic pyridoxine fails to prevent the development of infantile spasms in ALDH7A-1-related epilepsy
Darrah Haffner, MD
05:30 PM - 06:30 PM PDT Abstract 6-004 - Diurnal Periodicity in Spontaneously Occurring High-Frequency Oscillations in Intracranial EEG
Gabrielle Taylor Petito
05:30 PM - 06:30 PM PDT Abstract 6-005 - Epilepsy Characteristics in Children With Neurofibromatosis type 1, What We Have Learnt From a Tertiary Center Five Years’ Experience
Abdulhafeez Khair, MD
05:30 PM - 06:30 PM PDT Abstract 7-001 - Online CME-Certified Expert Panel Discussion Improved Knowledge of Clinically-Relevant Information Regarding Cannabinoids Among Neurologists
Thomas Finnegan, Jr., PhD
05:30 PM - 06:30 PM PDT Abstract 7-002 - A SIGN Group’s Diverse Virtual Neurology Education Programs: Successes, Barriers, and Future Directions
Sophia Gillian Musacchio
05:30 PM - 06:30 PM PDT Abstract 7-003 - A Simulated Hospital in a COVID-19 Pandemic Environment for Undergraduate Neurology Students.
Jaime Toro, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 7-004 - Online CME-certified Case Challenges in Migraine Increase Knowledge and Competence Among Neurologists and PCPs
Thomas Finnegan, Jr., PhD
05:30 PM - 06:30 PM PDT Abstract 1-001 - Advanced Practice Providers in Neurocritical Care: Model for Orientation and Onboarding to Ensure Quality of Patient Care, APP Autonomy, Retention and Job Satisfaction
Tyler John Schaefer, PA
05:30 PM - 06:30 PM PDT Abstract 1-002 - RLS-0071-101 a study in healthy human volunteers demonstrates safety, complement and inflammatory effector target engagement activity of this novel peptide
Neel Krishna, PhD
05:30 PM - 06:30 PM PDT Abstract 1-003 - Diabetic Striatopathy, a rare complication of uncontrolled diabetes: A review of distinct clinical presentations of three different cases
Navreet Kaur, MBBS
05:30 PM - 06:30 PM PDT Abstract 1-004 - Feasibility and safety of the Metaneb® System in neurocritical care patients
Evien Albazi
05:30 PM - 06:30 PM PDT Abstract 1-005 - A Rare Case of Acute Toxic Leukoencephalopathy: Is Sevoflurane the Culprit?
Saleem Mohamad Al Mawed, MD
05:30 PM - 06:30 PM PDT Abstract 1-006 - Guillain-Barre Syndrome after Influenza Vaccination in Adults
Tarek Elshourbagy
05:30 PM - 06:30 PM PDT Abstract 10-001 - Sustainability of Seizure Control With Adjunctive Cenobamate in the Phase 3 C021 Study
David G. Vossler, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 10-002 - Phase 2 Open-label Clinical Study Evaluating Oral Ganaxolone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex
Mary Kay Koenig, MD
05:30 PM - 06:30 PM PDT Abstract 10-003 - An Open-Label Pilot Trial Assessing the Safety and Efficacy of SPN-817 (Huperzine A Extended-Release) in Adults with Treatment-Resistant Focal Impaired Awareness Seizures
Jeanelle Portelli, PhD
05:30 PM - 06:30 PM PDT Abstract 10-004 - Fenfluramine Improves Everyday Executive Functioning in Patients With Lennox-Gastaut Syndrome: Analysis of Phase 3 Data
Kim I. Bishop, PhD
05:30 PM - 06:30 PM PDT Abstract 10-005 - Effect of Add-on Cannabidiol (CBD) on Seizure Frequency and Seizure-Free Intervals in Patients With Seizures Associated With Tuberous Sclerosis Complex (TSC): Phase 3 Trial GWPCARE6 Post Hoc Analysis
Steven Paul Sparagana, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 10-006 - Phase 2b Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE)
Jacqueline French, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 10-007 - Efficacy and Safety of Cannabidiol (CBD) Dose Adjustment in Patients With Lennox-Gastaut Syndrome (LGS): Post Hoc Analysis of Phase 3 Randomized Controlled Trial (RCT) GWPCARE3 and Open-Label Extension (OLE) Trial GWPCARE5
Timothy B. Saurer, PhD
05:30 PM - 06:30 PM PDT Abstract 4-001 - Modified Frailty Index (mFI) in Elderly Patients with Glioblastoma Correlates with Survival
Amy Khine Chang
05:30 PM - 06:30 PM PDT Abstract 4-002 - Feasibility of an Electronic Patient Reported Steroid Toxicity Monitoring Program in Patients with Malignant Gliomas
Andrea C. Wasilewski, MD
05:30 PM - 06:30 PM PDT Abstract 4-003 - Disparities in Pediatric Medulloblastoma: A Large Center’s Outcomes and Review of the Literature
Karthik Jagannath, MD
05:30 PM - 06:30 PM PDT Abstract 4-004 - Summary of virtual tumor board platforms and implementation in Neuro-Oncology
Chukwuyem Ekhator
05:30 PM - 06:30 PM PDT Abstract 4-005 - Disparities in Enrollment of Primary CNS Lymphoma Trials in the US
Camille Stevenson
05:30 PM - 06:30 PM PDT Abstract 4-006 - Validation of the Chimeric Antigen Receptor (CAR) T-cell Therapy Neurotoxicity: A Single Center Study
Carlen Amy Yuen, MD
05:30 PM - 06:30 PM PDT Abstract 4-007 - The Impact of COVID-19 on Neuro-Oncology Clinical Trials During Wave 1 and Wave 2 at a Frontline Detroit Healthcare System
Carmen Griffin, Other
05:30 PM - 06:30 PM PDT Abstract 13-001 - Acute Ischemic Stroke Patients Receiving Reperfusion Therapy Do Not Have Worse 90-day Outcomes After Delirium
Mohammad Jamil Ahmad, MD
05:30 PM - 06:30 PM PDT Abstract 13-002 - Predicting Aneurysmal Etiology Using Admission Head CT in Patients with Aneurysmal Pattern Subarachnoid Hemorrhage
Karl Viktor Baumgartner
05:30 PM - 06:30 PM PDT Abstract 13-003 - Association of External Ventricular Drain Duration and Outcomes in Aneurysmal Subarachnoid Hemorrhage: a Single Center Study
Wendy Elizabeth Gonzalez, Other
05:30 PM - 06:30 PM PDT Abstract 13-004 - Association Between Asymptomatic Cerebral Vasospasm and Outcomes in Aneurysmal Subarachnoid Hemorrhage
Alizeh Shamshad
05:30 PM - 06:30 PM PDT Abstract 13-005 - Assessing Thrombectomy Capacity and Characteristics of Thrombectomy Capable Centers World-wide Using the MT2020+ Global Thrombectomy Tracking Smartphone App ?
Syed F. Zaidi, MD
05:30 PM - 06:30 PM PDT Abstract 13-006 - Induction of Vasodilation to Prevent Ophthalmic Complications Before Middle Meningeal Artery Embolization
Kiana Moussavi, MD
05:30 PM - 06:30 PM PDT Abstract 13-007 - Identification of large vessel occlusion on CTA head using artificial intelligence
James Michael Hillis, MD
05:30 PM - 06:30 PM PDT Abstract 13-008 - Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage
Ryan Snow
05:30 PM - 06:30 PM PDT Abstract 13-009 - Post-Thrombectomy Outcome is Not Associated with Administration of Intravenous Thrombolysis
Amanda Jin Zhao, MD
05:30 PM - 06:30 PM PDT Abstract 13-010 - Blood Pressure Changes Impact Corticospinal Connectivity and Downstream Gait and Balance Control
Elizabeth A. Coon, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 5-001 - Treatment of Camptocormia in Parkinsonism: A Comparison of Different Interventions in a Single Center
Carly Jo Olszewski
05:30 PM - 06:30 PM PDT Abstract 5-002 - A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia
Peter J. McAllister, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 5-003 - Rare Variants In ARSA Are Associated With Parkinson's Disease
Konstantin Senkevich, MD
05:30 PM - 06:30 PM PDT Abstract 5-004 - VCP Mutations and Parkinsonism: An Emerging Link
Ashley Mary Paul, MD
05:30 PM - 06:30 PM PDT Abstract 5-005 - DNA Methylation-based Surrogates of Plasma Proteins are associated with Parkinson's Disease Risk
Katherine Fu, MD
05:30 PM - 06:30 PM PDT Abstract 5-006 - Transcriptome patterns and their regulation by alternative splicing in Parkinson’s disease.
Krithi Irmady, MBBS, MD
05:30 PM - 06:30 PM PDT Abstract 5-007 - Remote follow up of prodromal Parkinson's disease in a LRRK2 G2019S cohort
Ruth Schneider, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 2-001 - Neurological Outcomes of Organ Transplantation: A Systematic Review
Jenny Paola Garzon, MD
05:30 PM - 06:30 PM PDT Abstract 2-002 - Progressive Multifocal Leukoencephalopathy in immunocompetent a case report and review of literature
Syed Hassan Khalid, MD, MBBS
05:30 PM - 06:30 PM PDT Abstract 2-003 - Treatment Challenges of Active Multiple Sclerosis in the Setting of Cryptococcal Meningitis: A Case Report and Review of the Literature
Crystal A. Honold, APN, CNS
05:30 PM - 06:30 PM PDT Abstract 2-004 - Bannwarth Syndrome Mimicking Neurolymphomatosis
Sanem Pinar Uysal, MD
05:30 PM - 06:30 PM PDT Abstract 2-005 - Brainstem Gliomatosis Cerebri Presenting as a Cerebellopontine Angle Tumor
Kayla Schusterman
05:30 PM - 06:30 PM PDT Abstract 11-001 - Quantitative muscle analysis in FSHD using Whole-Body MRI: Composite Muscle Measurements for Cross-Sectional Analysis
Jennifer *Use 325910 Shoskes, PharmD
05:30 PM - 06:30 PM PDT Abstract 11-002 - Regional Body Composition in Myotonic Dystrophy Type 2: Associations of Lower Extremity Lean Mass Index and Clinical Endpoints
Carolyn Foster Aldendail, MD
05:30 PM - 06:30 PM PDT Abstract 11-003 - ADSSL1 Myopathy: A Case Report
David Atherton, MD
05:30 PM - 06:30 PM PDT Abstract 11-004 - Pharmacokinetics, Biodistribution, and Exploration of the Mechanism of Central Nervous System Penetration of a PATrOL™-Enabled Investigational Genetic Therapy for Myotonic Dystrophy, Type 1 after a Single Subcutaneous or Intravenous Administration in the BALB/c Murine Model
Barry A. Badeau, PhD
05:30 PM - 06:30 PM PDT Abstract 11-005 - Creatine kinase A Novel Prognostic Marker in GBS
Kaushik S, Jr., MD
05:30 PM - 06:30 PM PDT Abstract 11-006 - Sciatic Nerve Mononeuropathy After An Uncomplicated Vaginal Delivery
Nader Gamil Boutros, MD
05:30 PM - 06:30 PM PDT Abstract 11-007 - Super Slow Conduction Velocities in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Jeremy Zung, MD
05:30 PM - 06:30 PM PDT Abstract 11-008 - Optimization of intrathecal delivery of an infused AAV9 vector for delivery of a gene therapy candidate for Adrenomyeloneuropathy (AMN) in Non-Human Primates (NHP)
Vidyullatha Vasireddy, PhD
05:30 PM - 06:30 PM PDT Abstract 11-009 - Understanding the Adrenomyeloneuropathy (AMN) Patient Journey
Rohan Gandhi, PhD
05:30 PM - 06:30 PM PDT Abstract 11-010 - Gender Differences in the Development of Cardiomyopathy in Friedreich's Ataxia Patients: A Retrospective Study.
Yoona Lee, MD
Faculty Disclosures
Cheryl H. Waters, MD, FAAN Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal.
Sharp James David, PhD, MBBS The institution of Prof. David has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rugby Football Union. Prof. David has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Guarantors of Brain. The institution of Prof. David has received research support from UK Dementia Research Institute. The institution of Prof. David has received research support from ADVANCE Charity. The institution of Prof. David has received research support from Action Medical Research. The institution of Prof. David has received research support from Medical Research Council UK.
Durgesh Chaudhary, MBBS Dr. Chaudhary has nothing to disclose.
Aiden Meyer Mr. Meyer has received research support from Brown University - Undergraduate Teaching and Research Award.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Ulrich Thienel, MD,PhD Dr. Thienel has received personal compensation for serving as an employee of ReAlta Life Sciences. Dr. Thienel has received stock or an ownership interest from ReAlta Life Sciences.
Setty Magana, MD, PhD Dr. Magana has nothing to disclose.
Joyutpal Das, MBBS Dr. Das has nothing to disclose.
Katherine Fu, MD Dr. Fu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology: Neurology Journal .
Kranthi Kiran Mandava Mr. Mandava has nothing to disclose.
Mohammad Jamil Ahmad, MD Dr. Ahmad has nothing to disclose.
Michelle L. Mellion, MD Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Aurora has stock in Impel Neurpharma.
Jamil Ahmad, PhD Dr. Ahmad has nothing to disclose.
Katherine Patricia Andriole, PhD Dr. Andriole has nothing to disclose.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Dejan Jakimovski, MD, PhD Dr. Jakimovski has nothing to disclose.
Anna Castillo Anna Castillo has nothing to disclose.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Robert Vann, PhD Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Darrah Haffner, MD Dr. Haffner has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Naiser Law Office.
Jesse Menville Ms. Menville has nothing to disclose.
Paola Caroppo Paola Caroppo has nothing to disclose.
Raed Alroughani, MD, FAAN Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Bayer, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bayer, Biogen, Novartis, Merck, Roche, Sanofi.
Per Wildholm Per Wildholm has received personal compensation for serving as an employee of AMRA Medical.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Jennifer Ruskey, Other Ms. Ruskey has nothing to disclose.
Meghan Elizabeth Pawlik, MS Miss Pawlik has nothing to disclose.
Jack Grimshaw Mr. Grimshaw has nothing to disclose.
Thomas J. Kelly, MD No disclosure on file
Ahmed Ezzeldein Omran, MD Dr. Omran has nothing to disclose.
Karl Viktor Baumgartner Mr. Baumgartner has nothing to disclose.
Anneke Van Der Walt, MD Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Amanda Jin Zhao, MD Ms. Zhao has nothing to disclose.
Kate Burslem, Other Ms. Burslem has received personal compensation for serving as an employee of AbbVie. Ms. Burslem has received stock or an ownership interest from AbbVie.
Roger J. Porter, MD, FAAN Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received publishing royalties from a publication relating to health care.
Floor Jansen Floor Jansen has nothing to disclose.
John Fak, Other Mr. Fak has nothing to disclose.
Syed F. Zaidi, MD Dr. Zaidi has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai.
Maria Paula Silva Sanchez No disclosure on file
Barry A. Badeau, PhD Dr. Badeau has received personal compensation for serving as an employee of NeuBase Therapeutics.
Samir Sadik Al-Ghazawi, MD Dr. Al-Ghazawi has nothing to disclose.
Chukwuyem Ekhator Mr. Ekhator has nothing to disclose.
Nujud Farag, MD Dr. Farag has nothing to disclose.
Bradford B. Thompson, MD Dr. Thompson has nothing to disclose.
Guy Laureys, MD, PhD The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Laureys has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Michael H. Lev, MD Michael H. Lev, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda, Roche-Genetech. The institution of Michael H. Lev, MD has received research support from GE. Michael H. Lev, MD has received publishing royalties from a publication relating to health care.
Nader Gamil Boutros, MD Dr. Boutros has nothing to disclose.
Aliza Dworkind, Other Miss Dworkind has nothing to disclose.
Niral K. Patel, MD Dr. Patel has nothing to disclose.
Andrea Loggini, MD, MBA Dr. Loggini has nothing to disclose.
Bejoy Thomas No disclosure on file
Natalia Shor, MD Dr. Shor has nothing to disclose.
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Brandi Lee Anderson, NP Mrs. Anderson has nothing to disclose.
Viktor Szeder, MD,PhD Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP.
Alexander Pantelyat, MD, FAAN Dr. Pantelyat has received personal compensation for serving as an employee of MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms, Inc.. Dr. Pantelyat has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kelly & Ignoffo Law Group. The institution of Dr. Pantelyat has received research support from NIH/NIA.
Wendy Elizabeth Gonzalez, Other Miss Gonzalez has nothing to disclose.
Federico Silva, MD Federico Silva, MD has nothing to disclose.
Saloni Sharma, MBBS Dr. Sharma has nothing to disclose.
Kelly G. Knupp, MD Dr. Knupp has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for zogenix. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for encoded. Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for stoke. The institution of Dr. Knupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW pharmaceuticals. Dr. Knupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research.
Roy Alcalay, MD Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Burcu Zeydan, MD The institution of Dr. Zeydan has received research support from National Institutes of Health.
Jessica Tate, MD The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
Trisha Raelynn Dickey, MD Dr. Dickey has nothing to disclose.
Sophia Gillian Musacchio Ms. Musacchio has nothing to disclose.
Noah Rosen, MD, FAAN Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen/ Novartis. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Speaker with American Headache Society.
Peggy Auinger Ms. Auinger has nothing to disclose.
Ake TzuHui Lu, PhD Dr. Lu has nothing to disclose.
Thomas Jackson Mr. Jackson has nothing to disclose.
Shubhangi Shahaji Peche, MD An immediate family member of Dr. Peche has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silk Road medical .
Leo Hong-Li Wang, MD, PhD, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Oury Monchi, PhD The institution of Dr. Monchi has received research support from Canadian Health Research Institutes. The institution of Dr. Monchi has received research support from National Science and Engineering and Research Council of Canada. The institution of Dr. Monchi has received research support from Brain Canada Parkinson Canada.
Penina Krieger, MD Ms. Krieger has nothing to disclose.
Chelsea Borta, PA Mrs. Borta has nothing to disclose.
Carolyn Foster Aldendail, MD Dr. Foster Aldendail has nothing to disclose.
Murat Terzi, PhD Dr. Terzi has nothing to disclose.
Tracy Ming-Chun Yu, MD Dr. Yu has nothing to disclose.
Sonja Waltraud Scholz, MD, FAAN Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. An immediate family member of Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. The institution of Dr. Scholz has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Scholz has received research support from National Institutes of Health. An immediate family member of Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Council Member with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with JAMA Neurology that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with Journal of Parkinson's Disease that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The Multiple System Atrophy Coalition that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The GBA1 Canada Initiative (G-Can) that is relevant to AAN interests or activities.
Maria Assunta Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Scott Moody Scott Moody has nothing to disclose.
Kunal V. Desai, MD Dr. Desai has nothing to disclose.
Yoona Lee, MD Ms. Lee has nothing to disclose.
Schiffon Wong Schiffon Wong has received personal compensation for serving as an employee of EMD Serono.
Matthew Senjem Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Jai Grewal, MD The institution of Dr. Grewal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivacitas Oncology. The institution of Dr. Grewal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Grewal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BRANY IRB. Dr. Grewal has received stock or an ownership interest from Genomet, Inc. The institution of Dr. Grewal has received research support from Oncoceutics Pharmaceuticals.
Yedda Li, MD, PhD No disclosure on file
Paula R. Clemens, MD The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Jurriaan Peters, MD Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Alexandra Estelle Sankovic, MD Dr. Sankovic has nothing to disclose.
Ruth Schneider, MD, FAAN Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Escape Bio. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. The institution of Dr. Schneider has received research support from NIH. The institution of Dr. Schneider has received research support from Acadia Pharmaceuticals. The institution of Dr. Schneider has received research support from CHDI. The institution of Dr. Schneider has received research support from Biohaven Pharmaceuticals. The institution of Dr. Schneider has received research support from Parkinson Study Group. The institution of Dr. Schneider has received research support from The Michael J. Fox Foundation. Dr. Schneider has received personal compensation in the range of $500-$4,999 for serving as a Telemedicine Evaluator with Parkinson's Foundation.
Alrabi Tawil, MD, FAAN Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DYNE Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharma. Dr. Tawil has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for miRecule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care. Dr. Tawil has received publishing royalties from a publication relating to health care.
Tarek Elshourbagy Tarek Elshourbagy has nothing to disclose.
Abdullah Al-Asmi, MD No disclosure on file
Farnaz Asayesh, Other Ms. Asayesh has nothing to disclose.
William E. Rosenfeld, MD, FAAN The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Peter J. McAllister, MD, FAAN Dr. McAllister has received personal compensation for serving as an employee of Revance. Dr. McAllister has received personal compensation for serving as an employee of AbbVie. Dr. McAllister has received personal compensation for serving as an employee of Merz. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for teva. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biohaven. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Mustafa S. Siddiqui, MD, FAAN Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Daniele Litterio A. Spitaleri Daniele Litterio A. Spitaleri has received research support from Novartis.
KP Divya KP Divya has nothing to disclose.
Natalie Grant Natalie Grant has nothing to disclose.
Neel Krishna, PhD Dr. Krishna has received personal compensation for serving as an employee of ReAlta Life Sciences. Dr. Krishna has received intellectual property interests from a discovery or technology relating to health care.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Parvathi Kumar, MBBS Dr. Kumar has received personal compensation for serving as an employee of ReAlta Life Sciences Inc. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ReAlta Life Sciences Inc.
Jessica Lee, PhD Dr. Lee has received personal compensation for serving as an employee of Syneos Health.
Kathy Merlo, Other Mrs. Merlo has nothing to disclose.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Tia Chakraborty, MD Dr. Chakraborty has nothing to disclose.
Huw R. Morris, MD, PhD Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Morris has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Personal injury / Negligence cases. The institution of Dr. Morris has received research support from Parkinson's UK. The institution of Dr. Morris has received research support from Michael J Fox Foundartion. The institution of Dr. Morris has received research support from Cure Parkinson's Trust. The institution of Dr. Morris has received research support from PSP Association. The institution of Dr. Morris has received research support from CBD Solutions. The institution of Dr. Morris has received research support from Drake Foundation. The institution of Dr. Morris has received research support from Medical Research Council. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Cure PSP that is relevant to AAN interests or activities. Dr. Morris has a non-compensated relationship as a Scientific Advisory Board with Parkinson's UK that is relevant to AAN interests or activities.
Ana Garcia No disclosure on file
Ziv Gan-Or, MD, PhD Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Michael A. Rogawski, MD, PhD Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Joseph Sullivan Joseph Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epygenix. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded Therapetucis. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Invitate. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwigh Biosciences. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Knopp Biosciences. Joseph Sullivan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Asceneuron. Joseph Sullivan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Law Firms. Joseph Sullivan has received stock or an ownership interest from Epygenix Therapeutics. The institution of Joseph Sullivan has received research support from Zogenix. The institution of Joseph Sullivan has received research support from Marinus Pharmaceuticals. The institution of Joseph Sullivan has received research support from Stoke Therapeutics. The institution of Joseph Sullivan has received research support from Encoded Therapeutics. The institution of Joseph Sullivan has received research support from BioPharm solutions.
Jonathan Rubin, MD Dr. Rubin has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Rubin has received stock or an ownership interest from Supernus Pharmaceuticals. Dr. Rubin has received stock or an ownership interest from Atentiv.
Ashley Mary Paul, MD Dr. Paul has nothing to disclose.
Farhad Sahebkar-Moghaddam, MD Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
Beate Ritz Beate Ritz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Psychocultural Research. Beate Ritz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Tillery Korein Law firm. Beate Ritz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Andrus Wagstaff law firm. The institution of Beate Ritz has received research support from NIH. The institution of Beate Ritz has received research support from MJFox foundation. The institution of Beate Ritz has received research support from Dept of Defense. The institution of Beate Ritz has received research support from NASA. The institution of Beate Ritz has received research support from MSA foundation.
Showly Nicholson Mr. Nicholson has nothing to disclose.
Claudia Maria Brito Pires, Other Miss Brito Pires has nothing to disclose.
Mark Girgis, DO Dr. Girgis has nothing to disclose.
Abdelrahman M. Attia, II, MD Dr. Attia has nothing to disclose.
Shu Ching Wu, Other Mrs. WU has nothing to disclose.
Florian Eichler, MD An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
William Mann, PhD Dr. Mann has received personal compensation for serving as an employee of NeuBase Therapeutics, Inc..
Darren Ball Mr. Ball has nothing to disclose.
Ernesto Aycardi, MD Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Linda C. Wendell, MD, FAAN Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. An immediate family member of Dr. Wendell has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Wendell has stock in Apple. An immediate family member of Dr. Wendell has stock in Apple.
Jonatan Hornik, MD Dr. Hornik has nothing to disclose.
Scott Przybelski Scott Przybelski has nothing to disclose.
Silvia Basaia Silvia Basaia has nothing to disclose.
Francesca Caso, MD Dr. Caso has nothing to disclose.
Nicholas S. Potter, MD, PhD Dr. Potter has nothing to disclose.
Julius Latorre, MD, FAAN Dr. Latorre has nothing to disclose.
James Michael Hillis, MD Dr. Hillis has stock in Elly Health. The institution of Dr. Hillis has received research support from GE Healthcare. The institution of Dr. Hillis has received research support from Annalise.ai. The institution of Dr. Hillis has received research support from Viz.ai. Dr. Hillis has received intellectual property interests from a discovery or technology relating to health care.
Emily Hartman, Other Ms. Hartman has nothing to disclose.
Alicia Zha, MD Dr. Zha has nothing to disclose.
Kourosh Rezania, MD, FAAN Dr. Rezania has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Akcea. Dr. Rezania has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Peter Isquith Peter Isquith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Global Pharma Consultancy, LLC. Peter Isquith has received publishing royalties from a publication relating to health care.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Serge Przedborski, MD, PhD Dr. Przedborski has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eLife. The institution of Dr. Przedborski has received research support from NIH. The institution of Dr. Przedborski has received research support from DoD. The institution of Dr. Przedborski has received research support from Ludwig Foudantion. The institution of Dr. Przedborski has received research support from CZI.
Stanley Fahn, MD, FAAN Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Salim Chahin, MD Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Chahin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Chahin has received research support from National MS Society. The institution of Dr. Chahin has received research support from BMS.
Renee Wilson Renee Wilson has nothing to disclose.
Giacomina Rossi, PhD Dr. Rossi has nothing to disclose.
Tracy J. Koehler Tracy J. Koehler has nothing to disclose.
Hsin-Hsi Tsai, MD Dr. Tsai has nothing to disclose.
Marcela Cardona No disclosure on file
Stephen Falchek, MD Dr. Falchek has nothing to disclose.
Jeanelle Portelli, PhD Dr. Portelli has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
Praveen Ramani, MBBS Dr. Ramani has nothing to disclose.
Lynda Krasenbaum Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Mohammad Obadah Nakawah, MD Dr. Nakawah has nothing to disclose.
Elyse Forman Miss School has nothing to disclose.
Jeremy Zung, MD Dr. Zung has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Internal Medicine Review.
Santosh Kesari, MD, PhD, FAAN Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
Kristen Bolte Miss Bolte has nothing to disclose.
Ahmed Z. Obeidat, MD, PhD Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities.
Rajeshwari Mahalingam, MD Dr. Mahalingam has nothing to disclose.
Araya Puwanant, MD The institution of Dr. Puwanant has received research support from Muscular Dystrophy Association. The institution of Dr. Puwanant has received research support from NIH/NINDS. The institution of Dr. Puwanant has received research support from NIH/NINDS.
Katy Eichinger, PT,PhD, DPT, NCS Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FSHD Society. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Filterlex. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for 3D Communications. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurology Live. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Bethanie N. Morgan, MD Dr. Morgan has nothing to disclose.
Jorge A. Vidaurre, MD Dr. Vidaurre has nothing to disclose.
Elaine C. Wirrell, MD, FAAN Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Crystal A. Honold, APN, CNS Mrs. Honold has nothing to disclose.
Rohan Gandhi, PhD Dr. Gandhi has received personal compensation for serving as an employee of Autobahn Therapeutics. Dr. Gandhi has stock in Autobahn Therapeutics.
Paolo Zanotti Fregonara Paolo Zanotti Fregonara has nothing to disclose.
Violiza A. Inoa, MD No disclosure on file
Uma Maheswari E Uma Maheswari E has nothing to disclose.
Amy Khine Chang Miss Chang has nothing to disclose.
Rima Nabbout No disclosure on file
Jared Scripture, PhD Dr. Scripture has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven Pharmaceuticals.
Jiwon Oh, MD, FAAN Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Sanem Pinar Uysal, MD Dr. Uysal has nothing to disclose.
Rajalakshmi Poyuran, MD Dr. POYURAN has nothing to disclose.
Nabeel Herial, MD, MPH, FAAN Dr. Herial has nothing to disclose.
Emma Drysdale Ms. Drysdale has received personal compensation for serving as an employee of Syneos Health.
Robert G. Holloway, MD, MPH, FAAN Dr. Holloway has nothing to disclose.
Brenda E. Porter, MD, PhD An immediate family member of Dr. Porter has received personal compensation for serving as an employee of Sangamo. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha. An immediate family member of Dr. Porter has received stock or an ownership interest from Johnson and Johnson.
Linda Harris, MPH Ms. Harris has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Harris has received stock or an ownership interest from Biohaven Pharmaceuticals.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Kimberly C. Paul, PhD The institution of Dr. Paul has received research support from NIH. The institution of Dr. Paul has received research support from Michael J Fox Foundation.
Camille Stevenson Miss Stevenson has nothing to disclose.
Bernardo Canedo Bizzo The institution of Dr. Canedo Bizzo has received research support from GE Healthcare.
Ryan Snow Mr. Snow has nothing to disclose.
Chan Beals Chan Beals has received personal compensation for serving as an employee of Autobahn Therapeutics.
Lauren Hurst Ms. Hurst has nothing to disclose.
Sean Tobyne, PhD Dr. Tobyne has received personal compensation for serving as an employee of Linus Health. Dr. Tobyne has received personal compensation for serving as an employee of Charles River Analytics. Dr. Tobyne has received stock or an ownership interest from Charles River Analytics. The institution of Dr. Tobyne has received research support from National Institutes of Health.
Jason Buroker, Other Mr. Buroker has nothing to disclose.
Kaitlin Schoder, NP Ms. Schoder has nothing to disclose.
Konstantin Senkevich, MD The institution of Dr. Senkevich has received research support from MJFF. Dr. Senkevich has received research support from HBHL. Dr. Senkevich has received research support from FRQS.
Andrew Russo Andrew Russo has nothing to disclose.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Bassem I. Yamout, MD, FAAN Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yamout has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Adrienne M. Keener, MD Dr. Keener has nothing to disclose.
Christopher Philip Bridge, PhD The institution of Dr. Bridge has received research support from GE Healthcare. The institution of Dr. Bridge has received research support from Nvidia Corporation. Dr. Bridge has received intellectual property interests from a discovery or technology relating to health care.
Elijah Malik Persad-Paisley Mr. Persad-Paisley has nothing to disclose.
Patrizia Pantano Patrizia Pantano has nothing to disclose.
Michele Joseph Michele Joseph has nothing to disclose.
Sara E. Sacco, MD The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel Neuropharma. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TEVA. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI (Now Collegium). The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Sacco has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel NeuroPharma. Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Key Opinion Leader with Teva.
Elizabeth Michel, PA Mrs. Michel has nothing to disclose.
Emile Sami Moukheiber, MD Dr. Moukheiber has nothing to disclose.
Mohamed Fahmy Doheim Mr. Doheim has nothing to disclose.
Nkechi Obianozie, MBBS Dr. Obianozie has nothing to disclose.
Syed Hassan Khalid, MD, MBBS Dr. Khalid has nothing to disclose.
Kehan Zhao, MD Dr. Zhao has nothing to disclose.
Santiago Ortega Gutierrez, MD Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.
Tamara Zach, MD, FAAN Dr. Zach has nothing to disclose.
Robert I. Reid Robert I. Reid has received research support from Mayo Clinic Foundation.
Jennifer A. Frontera, MD Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FirstKindMedical. Dr. Frontera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician Education Resource. The institution of Dr. Frontera has received research support from NIH. The institution of Dr. Frontera has received research support from Alexion. Dr. Frontera has received publishing royalties from a publication relating to health care.
Sisira Yadala, MD, FAAN Dr. Yadala has nothing to disclose.
Gloria Von Geldern, MD, FAAN The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from National MS Society. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities.
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Yi-Chien Liu, MD Dr. Liu has nothing to disclose.
John A. Morren, MD, FAAN Dr. Morren has received publishing royalties from a publication relating to health care.
Alexandra N. Kaplan Ms. Kaplan has nothing to disclose.
Jinjie Liu, Other Mrs. Liu has received personal compensation for serving as an employee of Genesis Research.
Suzanne J. Hodgkinson, MD, PhD, MBBS, FRACP The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Salman Zahoor, MBBS Dr. Zahoor has nothing to disclose.
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Kyla Beckman, PA Mrs. Beckman has nothing to disclose.
Ayse Altintas, MD Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Deva. The institution of Dr. Altintas has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Hira Zafar, MBBS Dr. Zafar has nothing to disclose.
Emmanuel Obusez, MD Dr. Obusez has nothing to disclose.
Jared Macher Mr. Macher has nothing to disclose.
Markus Karlsson, PhD Dr. Karlsson has received personal compensation for serving as an employee of AMRA Medical.
Ajith Cherian Ajith Cherian has nothing to disclose.
Gagana Kethaka Mallawa Arac Mallawaarachchi Mr. Mallawaarachchi has nothing to disclose.
Yvette Bordelon, MD, FAAN The institution of Dr. Bordelon has received research support from Neuraly. The institution of Dr. Bordelon has received research support from AbbVie.
Ian Miller, MD Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Michael Bishop Michael Bishop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Michael Bishop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kite/Gilead. Michael Bishop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Michael Bishop has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for BMS. Michael Bishop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Agios. Michael Bishop has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Incyte. Michael Bishop has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi.
Pu-Tien Chiang, MD Dr. Chiang has nothing to disclose.
Juan Sebastian Rivera Perez, MD Dr. Rivera Perez has nothing to disclose.
Laura Andrea Serna Miss Serna has nothing to disclose.
Charles Maitland Charles Maitland has nothing to disclose.
Harini Pavuluri Harini Pavuluri has nothing to disclose.
Ahmad A. Ballout, MD Dr. Ballout has nothing to disclose.
Jairo Alejandro Gaitan Alfonso, MD Dr. Gaitan Alfonso has nothing to disclose.
Michael Seminerio Michael Seminerio has received personal compensation for serving as an employee of AbbVie.
Jorge Luis Rodriguez Lee, MD Dr. Rodriguez Lee has nothing to disclose.
Anand R. Shewale Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
Dan Spiegelman Dan Spiegelman has nothing to disclose.
Anand Mamdani Anand Mamdani has nothing to disclose.
Hoon-Ki Min Hoon-Ki Min has nothing to disclose.
Veronica Castelnovo, MSc Dr. Castelnovo has nothing to disclose.
Sandra Rojas-Caro, MD Dr. Rojas-Caro has received personal compensation for serving as an employee of Gemini Therapeutics. Dr. Rojas-Caro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for HemoShear Therapeutics. Dr. Rojas-Caro has stock in Neubase Therapeutics.
Jumana Tariq A Alshaikh, MD Dr. Alshaikh has nothing to disclose.
Michael Dmitriy Kolesnik, DO Dr. Kolesnik has nothing to disclose.
B. Gwen Windham The institution of B. Gwen Windham has received research support from NIH.
Aysun Soysal, MD Dr. Soysal has nothing to disclose.
Taylor Myers Taylor Myers has nothing to disclose.
Domenico Vitarella Domenico Vitarella has received personal compensation for serving as an employee of Revance.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Karl Zimmerman No disclosure on file
Katherine D. Amodeo, MD The institution of Dr. Amodeo has received research support from Roche. The institution of Dr. Amodeo has received research support from EIP Pharma. The institution of Dr. Amodeo has received research support from Acadia. The institution of Dr. Amodeo has received research support from MJFF. The institution of Dr. Amodeo has received research support from NINDS.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Etienne Laverse, MBBS, BSc, MRCP Dr. Laverse has nothing to disclose.
Reza Sadjadi No disclosure on file
Yves Dauvilliers, MD, PhD Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.
Aaron Abramovitz, MD Dr. Abramovitz has nothing to disclose.
Isabella Canut Ms. Canut has nothing to disclose.
Ali Mahta, MD Dr. Mahta has nothing to disclose.
E. Ray Dorsey, MD, MBA Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainNeuroBio. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Clintrex. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali Therapeutics. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Grand Rounds. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medopad. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Michael J. Fox Foundation. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Origent Data Sciences, Inc.. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Otsuka. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion Pharma. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Alzheimer's Drug Discovery Foundation. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial-Biotech Investments, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BluePrint Orphan, Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caraway T. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DeciBio. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NACCME/CONSULTANT 360. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Dorsey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pear Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caraway. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Huntington Study Group. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Voyager. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCM Education. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Physician's Education Resource, LLC. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Karger. Dr. Dorsey has stock in Grand Rounds. The institution of Dr. Dorsey has received research support from Biogen - WATCH-PD. The institution of Dr. Dorsey has received research support from NIH - AHPD. Dr. Dorsey has received research support from NIH - Biosensics. The institution of Dr. Dorsey has received research support from Pfizer - SQUAD. The institution of Dr. Dorsey has received research support from Greater Rochester Health Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Safra Foundation - PDCNY. The institution of Dr. Dorsey has received research support from Burroughs Wellcome - Smartphones. The institution of Dr. Dorsey has received research support from NIH - CTSA. The institution of Dr. Dorsey has received research support from Gary & Mary West Foundation - d.health. The institution of Dr. Dorsey has received research support from PCORI -PD Virtual Care. The institution of Dr. Dorsey has received research support from WAVE Life Sciences. The institution of Dr. Dorsey has received research support from Acadia Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Roche Pharmaceuticals - PDTV. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from PCORI. The institution of Dr. Dorsey has received research support from Safra Foundation.
Evien Albazi Mrs. Albazi has nothing to disclose.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Cynthia L. Harden, MD Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Aaron S. Lord, MD Dr. Lord has nothing to disclose.
Azam Tolla, DO Dr. Tolla has nothing to disclose.
Ravindra Arya The institution of Ravindra Arya has received research support from National Institutes of Health. The institution of Ravindra Arya has received research support from Cincinnati Children's Research Foundation.
Kayla Schusterman Ms. Schusterman has nothing to disclose.
Daniela Sofia Rodriguez Ms. Rodriguez has nothing to disclose.
Delanie Lynch Ms. Lynch has nothing to disclose.
Jeremy Housekeeper Mr. Housekeeper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vidatak LLC.
Gurcharanjeet Kaur, MBBS Dr. Kaur has nothing to disclose.
Robert DiEgidio Mr. DiEgidio has received personal compensation for serving as an employee of Teva Branded Pharmaceutical Products R&D, Inc..
Roman Rubio Roman Rubio has received personal compensation for serving as an employee of Revance.
Brad Kemp Brad Kemp has nothing to disclose.
Joshua Alton, Other Mr. Alton has nothing to disclose.
Eric Yu, Other Mr. Yu has nothing to disclose.
Kaushik S, Jr., MD Dr. S has nothing to disclose.
Maryam Zulfiqar, MD Dr. Zulfiqar has nothing to disclose.
Craig William Scholle, Other Mr. Scholle has received personal compensation for serving as an employee of Cincinnati Childrens Hospital Medical Center.
Andrea C. Wasilewski, MD Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure.
Yi Xu No disclosure on file
Stuart Robert Pomerantz, MD Dr. Pomerantz has nothing to disclose.
Alizeh Shamshad Ms. Shamshad has nothing to disclose.
Muhammad Shahzad Zafar, MBBS Dr. Zafar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Zafar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova . The institution of Dr. Zafar has received research support from UCB. The institution of Dr. Zafar has received research support from SK life. The institution of Dr. Zafar has received research support from Marinus. The institution of Dr. Zafar has received research support from LivaNova. The institution of Dr. Zafar has received research support from Biopharma. The institution of Dr. Zafar has received research support from Neurocrine. The institution of Dr. Zafar has received research support from Hartwell Foundation.
Sara Prioni Sara Prioni has nothing to disclose.
Azmi *use 306680 Nasser, PhD Dr. Nasser has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
Souhel Najjar, MD Dr. Najjar has nothing to disclose.
Jacob Sebaugh Mr. Sebaugh has nothing to disclose.
Jeff M. Bronstein, MD, PhD Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation.
Asmaa Khaled Alsiouty, Other Miss Alsiouty has nothing to disclose.
Fatima Ilemona Abdulai, MBBS Dr. Abdulai has nothing to disclose.
Francesco Falbo, MD Dr. Falbo has nothing to disclose.
Bradley *USE ID 014834 Galer Bradley Galer has received personal compensation for serving as an employee of Zogenix, Inc. Bradley Galer has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Zogenix, Inc. Bradley Galer has received stock or an ownership interest from Zogenix, Inc. Bradley Galer has received publishing royalties from a publication relating to health care.
Timothy Spelman Timothy Spelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Carly Jo Olszewski Ms. Olszewski has nothing to disclose.
Richard A L Macdonell, MD, FAAN Dr. Macdonell has nothing to disclose.
Nikolaos Petsas No disclosure on file
Youssef Ahmed Ragab Ali, MBBS Dr. Ali has nothing to disclose.
Paola Valsasina Paola Valsasina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACCMED.
Gregory Brooks No disclosure on file
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Val John Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Anas Zakarya Nourelden, Jr., MD Dr. Nourelden has nothing to disclose.
Hope Merkley, NP Ms. Merkley has nothing to disclose.
Annette Wundes, MD The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Elena Schmidt, MD Dr. Schmidt has nothing to disclose.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Sean Stern Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
David G. Vossler, MD, FAAN Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $0-$499 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals.
Brandon Francis, MD Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovian. Dr. Francis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Montgomery and Associates.
Blanca Yvette Valdovinos, MD Dr. Valdovinos has nothing to disclose.
Gail M. Farfel, PhD Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Durect Corp. Dr. Farfel has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Zogenix. Dr. Farfel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for AvroBio. Dr. Farfel has received intellectual property interests from a discovery or technology relating to health care.
Ani Eloyan Ani Eloyan has nothing to disclose.
Verena *use 212969 Ramirez Campos, MD Dr. Ramirez Campos has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Renta Hutabarat, PhD Dr. Hutabarat has nothing to disclose.
Elizabeth Thiele, MD Dr. Thiele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. An immediate family member of Dr. Thiele has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thor labs. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for takeda. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics.
Rajsekar R. Rajaraman, MD Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals.
Brian Ervin An immediate family member of Mr. Ervin has received personal compensation in the range of $100,000-$499,999 for serving as a Finance Director with City of Monroe. An immediate family member of Mr. Ervin has received personal compensation in the range of $5,000-$9,999 for serving as a Treasurer with Lebanon City Schools.
Johanna Evans Appleton, Other Ms. Appleton has nothing to disclose.
Karthik Jagannath, MD Mr. Jagannath has nothing to disclose.
Joseph Zachariah, DO Dr. Zachariah has nothing to disclose.
Carmen Griffin, Other Miss Griffin has nothing to disclose.
Nimish A. Mohile, MD, FAAN Dr. Mohile has nothing to disclose.
Chia-Ju Chou, PhD Miss Chou has nothing to disclose.
Antonio Gallo Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Ralph H. B. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Mark B. Skeen, MD, FAAN Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy.
David Robert Beers, PhD No disclosure on file
Keith Dreyer, Sr., DO,PhD Dr. Dreyer has nothing to disclose.
Martin Brodie Martin Brodie has nothing to disclose.
James P. Kesslak, PhD Dr. Kesslak has received personal compensation for serving as an employee of Alzheon. Dr. Kesslak has stock in Prime First Lending.
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Mariam Alsayd Alsayd, Jr., Other Dr. Alsayd has nothing to disclose.
Rashid Ali Ahmed, MD Dr. Ahmed has nothing to disclose.
Alejandro Hornik, MD Dr. Hornik has nothing to disclose.
Timothy B. Saurer, PhD Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Christopher J. Kenney, MD, FAAN Dr. Kenney has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Kenney has stock in Xenon Pharmaceuticals.
Reya *use 384344 Hayeks Ms. Hayek has nothing to disclose.
Dietrich A. Stephan, PhD Dr. Stephan has received personal compensation for serving as an employee of NeuBase Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from Peptilogics, Inc.. Dr. Stephan has received stock or an ownership interest from Sharp Edge Labs, Inc.. Dr. Stephan has received stock or an ownership interest from Pendulum Therapeutics, Inc.. Dr. Stephan has received stock or an ownership interest from FarmaceuticalRx.
Khaled Mohamed Ragab, MD Dr. Ragab has nothing to disclose.
Emilio Perucca Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW . Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shackelford. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SKB Life Sciences. The institution of Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PMI Life Sciences. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care. Emilio Perucca has received publishing royalties from a publication relating to health care.
Jenny Paola Garzon, MD Dr. Garzon has nothing to disclose.
Karen Kozarsky, PhD Dr. Kozarsky has received personal compensation for serving as an employee of SwanBio Therapeutics. Dr. Kozarsky has received stock or an ownership interest from SwanBio Therapeutics.
Mohamed Sayed Zaazouee Mr. Zaazouee has nothing to disclose.
Rebecca Knapp Ms. Knapp has nothing to disclose.
Brenda Shen Ms. Shen has nothing to disclose.
Thomas David Parker, PhD, BMBCh, MRCP Dr. Parker has nothing to disclose.
Gabrielle Taylor Petito Miss Petito has nothing to disclose.
Sarah Nava, NP Mrs. Nava has nothing to disclose.
Pradeep Mammen Pradeep Mammen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies. Pradeep Mammen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhaseBio Inc. . Pradeep Mammen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics . Pradeep Mammen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CareDx Inc. . Pradeep Mammen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CareDx Inc. . The institution of Pradeep Mammen has received research support from CareDx Inc.. The institution of Pradeep Mammen has received research support from National Institute of Health. The institution of Pradeep Mammen has received research support from Catabasis Inc. . The institution of Pradeep Mammen has received research support from PhaseBio Inc. . Pradeep Mammen has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer for various NIH Study Sections with National Institute of Health . Pradeep Mammen has received personal compensation in the range of $10,000-$49,999 for serving as a Member of the Grants Working Group with California Institute of Regenerative Medicine.
Leah Croll, MD Dr. Croll has nothing to disclose.
Camilla Cividini, MSc Ms. Cividini has nothing to disclose.
Erum Khan Ms. Khan has nothing to disclose.
Meredith A. Kriger, Other Mrs. Kriger has nothing to disclose.
Maurice Driessen Maurice Driessen has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Natasha Hameed, MD Dr. Hameed has nothing to disclose.
Stanley H. Appel, MD, FAAN Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Diego Silva Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Heidi Bien, Other Ms. Bien has nothing to disclose.
John R. Mytinger, MD Dr. Mytinger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Walter Kremers The institution of Walter Kremers has received research support from Biogen.
Yasmine Adel Mohammed, Other Dr. Mohammed has nothing to disclose.
Hildalicia Guerra, MD Dr. Guerra has nothing to disclose.
Sean W. Clark, PhD Dr. Clark has received personal compensation for serving as an employee of SwanBio Therapeutics. Dr. Clark has received personal compensation for serving as an employee of Amicus Therapeutics. Dr. Clark has received stock or an ownership interest from Amicus Therapeutics. Dr. Clark has received intellectual property interests from a discovery or technology relating to health care. Dr. Clark has received intellectual property interests from a discovery or technology relating to health care.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Saleem Mohamad Al Mawed, MD Dr. Al Mawed has nothing to disclose.
Christopher Schwarz Christopher Schwarz has received personal compensation for serving as an employee of Mayo Clinic. The institution of Christopher Schwarz has received research support from NIH.
Alicia Castonguay, PhD No disclosure on file
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Vidyullatha Vasireddy, PhD Dr. Vasireddy has stock in SwanBio Therapeutics.
Alissa Ashley Thomas, MD, FAAN Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roon. The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Baziel G M van Engelen, MD, MA, PhD The institution of Dr. van Engelen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Facio. The institution of Dr. van Engelen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum . The institution of Dr. van Engelen has received research support from Stichting Spieren voor Spieren. The institution of Dr. van Engelen has received research support from Prinses Beatrix Fonds. The institution of Dr. van Engelen has received research support from Dutch FSHD society. Dr. van Engelen has received intellectual property interests from a discovery or technology relating to health care.
Perry Shieh, MD, PhD, FAAN Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Ayatalla Ahmed, MBBS Dr. Ahmed has nothing to disclose.
Christoph Stretz, MD, FAAN Dr. Stretz has nothing to disclose.
Timothy Lesnick Timothy Lesnick has received personal compensation for serving as an employee of Mayo Clinic.
Ramon Gilberto Gonzalez, MD,PhD Dr. Gonzalez has nothing to disclose.
Tyler John Schaefer, PA Mr. Schaefer has nothing to disclose.
Koto Ishida, MD, FAAN Dr. Ishida has received publishing royalties from a publication relating to health care.
Ildebrando H. Appollonio, MD Dr. Appollonio has nothing to disclose.
Benjamin Carroll Grant, PA Mr. Grant has nothing to disclose.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Sutapa Ray, PhD Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Ariane Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Lior Greenbaum, MD,PhD Dr. Greenbaum has nothing to disclose.
David William Anderson, PhD Dr. Anderson has received personal compensation for serving as an employee of SwanBio Therapeutics Inc. Dr. Anderson has received personal compensation for serving as an employee of Spark Therapeutics Inc. An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of GSK. An immediate family member of Dr. Anderson has received personal compensation for serving as an employee of Novartis. Dr. Anderson has stock in SwanBio Therapeutics Inc. An immediate family member of Dr. Anderson has stock in GSK. Dr. Anderson has stock in Roche . An immediate family member of Dr. Anderson has stock in Novartis.
Stella Jensen-Roberts Ms. Jensen-Roberts has nothing to disclose.
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Barry E. Gidal, PhD Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SK life sciences . Dr. Gidal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Gidal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK life science .
Jaya Raghav Trivedi, MD, FAAN Dr. Trivedi has nothing to disclose.
James Snyder, DO Dr. Snyder has nothing to disclose.
Todd Gross Todd Gross has received personal compensation for serving as an employee of Revance Therapeutics Inc. Todd Gross has stock in Revance Therapeutics Inc.
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Bethany Williams, PhD Dr. Williams has received research support from UTHealth at Houston.
Gerard A. Gioia, MD Dr. Gioia has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Pharma Consultancy. Dr. Gioia has received publishing royalties from a publication relating to health care.
Gregory Busse Gregory Busse has received personal compensation for serving as an employee of Supernus Pharmaceuticals.
Danielle Diekevers Danielle Diekevers has nothing to disclose.
Ronald C. Petersen, PhD, MD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Steven Paul Sparagana, MD, FAAN Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
Thomas Felipe Medina Ramirez Mr. Medina Ramirez has nothing to disclose.
Carlen Amy Yuen, MD Dr. Yuen has nothing to disclose.
Hagar Adel Abuelazm Dr. ABUELAZM has nothing to disclose.
Jay Han, MD No disclosure on file
John Maeglin Mr. Maeglin has nothing to disclose.
Maria Alejandra Garcia-Dominguez, MD Dr. Garcia-Dominguez has nothing to disclose.
Michelle M. Mielke, PhD Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk.
Charles J. Lu, Other Mr. Lu has nothing to disclose.
Jaime Toro, MD, FAAN Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
Adefowope Odueyungbo, PhD Dr. Odueyungbo has received personal compensation for serving as an employee of Fulcrum Therapeutics.
Ahmed Sayed, Other Dr. Sayed has nothing to disclose.
Steve Horvath, PhD Dr. Horvath has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epigenetic Clock Development Foundation. Dr. Horvath has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Epigenetick Clock Development Foundation. The institution of Dr. Horvath has received research support from Open Philantropy. Dr. Horvath has received intellectual property interests from a discovery or technology relating to health care.
David Atherton, MD Dr. Atherton has nothing to disclose.
Kenji Mason Cunnion, MD Dr. CUNNION has received personal compensation for serving as an employee of ReAlta Life Sciences. An immediate family member of Dr. CUNNION has received stock or an ownership interest from ReAlta Life Sciences.
Nilo Riva Nilo Riva has nothing to disclose.
Mary Kay Koenig, MD Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stealth BioTherapeutics. Dr. Koenig has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Koenig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Abliva AB. The institution of Dr. Koenig has received research support from EryDel SPA. The institution of Dr. Koenig has received research support from PTC Therapeutics. The institution of Dr. Koenig has received research support from Noema Pharmaceuticals. The institution of Dr. Koenig has received research support from Marinus Pharmaceuticals. The institution of Dr. Koenig has received research support from Jazz Pharmaceuticals. The institution of Dr. Koenig has received research support from Nflexion Therapeutics. The institution of Dr. Koenig has received research support from Stealth BioTherapeutics. The institution of Dr. Koenig has received research support from Astellas Pharmaceuticals. The institution of Dr. Koenig has received research support from Reneo Pharmaceuticals.
Alexandra Helliwell Ms. Helliwell has nothing to disclose.
Masahiro Fujita No disclosure on file
Nayana Prabhu, MD Dr. Prabhu has nothing to disclose.
Robert T. Wechsler, MD, PhD, FAAN The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Raport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Walid Abdel-Aziz, MBBS Mr. Abdel-Aziz has nothing to disclose.
Sahar Sultana Anjum, MS Miss Anjum has nothing to disclose.
Menno M Schoonheim The institution of Menno M Schoonheim has received research support from Dutch MS Research Foundation. The institution of Menno M Schoonheim has received research support from Eurostars-EUREKA. The institution of Menno M Schoonheim has received research support from ARSEP. The institution of Menno M Schoonheim has received research support from Amsterdam Neuroscience. The institution of Menno M Schoonheim has received research support from MAGNIMS. The institution of Menno M Schoonheim has received research support from ZonMW. The institution of Menno M Schoonheim has received research support from Atara Biotherapeutics. The institution of Menno M Schoonheim has received research support from Biogen. The institution of Menno M Schoonheim has received research support from Celgene/Bristol Meyers Squibb. The institution of Menno M Schoonheim has received research support from Genzyme. The institution of Menno M Schoonheim has received research support from MedDay. The institution of Menno M Schoonheim has received research support from Merck.
Antonio Carotenuto Mr. Carotenuto has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk, Novartis, Roche and Almirall. The institution of Mr. Carotenuto has received research support from ALMIRALL. The institution of Mr. Carotenuto has received research support from Carotenuto Antonio.
Vincent Van Pesch, MD, PhD Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
Jeannette Lechner-Scott, MD, PhD, FRACP The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Ashley A. Weaver, PhD Dr. Weaver has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Elemance, LLC. Dr. Weaver has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for KLS Martin. The institution of Dr. Weaver has received research support from KLS Martin. The institution of Dr. Weaver has received research support from Toyota. The institution of Dr. Weaver has received research support from NASA. The institution of Dr. Weaver has received research support from NHTSA. The institution of Dr. Weaver has received research support from NIH. The institution of Dr. Weaver has received research support from NSF. The institution of Dr. Weaver has received research support from RCCADS.
Abdelhameed Nawwar, MD Dr. Nawwar has nothing to disclose.
Prashanthi Vemuri, PhD The institution of Dr. Vemuri has received research support from NIH.
Diana Alejandra Madrid, MS Miss Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Grantee with Institute of Internation Education. Miss Madrid has received personal compensation in the range of $500-$4,999 for serving as a Early Investigator Travel Award with American Society for Bone and Mineral Research. Miss Madrid has received personal compensation in the range of $0-$499 for serving as a Travel Award with American Neurological Association.
Julianne Lee, Other Ms. Lee has nothing to disclose.
Joseph C. Masdeu, MD, PhD, FAAN Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Simon Kemp Simon Kemp has nothing to disclose.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Darcy Krueger, MD Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Tobias Walbert, MD, PhD, FAAN Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.
Yolanda Blanco Morgado, MD Dr. Blanco Morgado has nothing to disclose.
Jose L. Torres, MD Dr. Torres has nothing to disclose.
Manuel S. Yepes, MD Dr. Yepes has nothing to disclose.
Kevin Alschuler Kevin Alschuler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Uber Technologies, Inc.. Kevin Alschuler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rehabilitation Psychology. Kevin Alschuler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Disability & Health Journal. The institution of Kevin Alschuler has received research support from National Multiple Sclerosis Society. The institution of Kevin Alschuler has received research support from National Institutes of Health. The institution of Kevin Alschuler has received research support from Patient Centered Outcomes Research Institute. Kevin Alschuler has received intellectual property interests from a discovery or technology relating to health care.
Bridget Russell, NP Mrs. Russell has nothing to disclose.
Paul Gong, MD Dr. Gong has nothing to disclose.
Fabián Cortés Fabián Cortés has nothing to disclose.
Ezgi Saylam, MD Dr. Saylam has nothing to disclose.
Finbar O'Callaghan Finbar O'Callaghan has nothing to disclose.
Oliver Gerlach Oliver Gerlach has nothing to disclose.
Stephen Bevan Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharma. Dr. Cadavid has received personal compensation for serving as an employee of Fulcrum Therapeutics. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvinas. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. Dr. Cadavid has received stock or an ownership interest from X4 Pharma. Dr. Cadavid has received stock or an ownership interest from Fulcrum Therapeutics.
Elizabeth A. Coon, MD, FAAN Dr. Coon has nothing to disclose.
Radek Ampapa, MD Dr. Ampapa has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzym.
Samantha Lettenberger, Other Miss Lettenberger has nothing to disclose.
Brendan Lujan, PhD Dr. Lujan has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc..
Michael Targowski, Other Mr. Targowski has nothing to disclose.
Milad Sabouri, DO Dr. Sabouri has nothing to disclose.
Aditya Kumar, MD Dr. Kumar has nothing to disclose.
Simon Pimstone Simon Pimstone has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Simon Pimstone has received stock or an ownership interest from Xenon Pharmaceuticals Inc.. Simon Pimstone has received research support from Genome BC / Genome Canada. Simon Pimstone has received intellectual property interests from a discovery or technology relating to health care.
Julia Marie Soto, MPH Julia Soto has nothing to disclose.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Marc Tian Mr. Tian has received personal compensation for serving as an employee of Teva Branded Pharmaceutical Products R&D, Inc..
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Lizeth Rodriguez No disclosure on file
Yann Nadjar The institution of Yann Nadjar has received research support from Takkeda.
Balasubramanian Samivel, MD Dr. Samivel has nothing to disclose.
Hagar Rohim Mrs. Rohim has nothing to disclose.
Alirexa Faridar, MD Dr. Faridar has nothing to disclose.
Abdulhafeez Khair, MD Dr. Khair has nothing to disclose.
David Rog, MBBS Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Rog has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen-Cilag. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rog has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. The institution of Dr. Rog has received research support from Actelion. The institution of Dr. Rog has received research support from Biogen. The institution of Dr. Rog has received research support from MedDay. The institution of Dr. Rog has received research support from Merck. The institution of Dr. Rog has received research support from Mitsubishi. The institution of Dr. Rog has received research support from Novartis. The institution of an immediate family member of Dr. Rog has received research support from Sanofi Genzyme. The institution of Dr. Rog has received research support from TG Therapeutics. Dr. Rog has received research support from Janssen-Cilag.
Alaa Elshanbary, MBBS Dr. Elshanbary has nothing to disclose.
Lucio Tremolizzo Lucio Tremolizzo has nothing to disclose.
Thomas Finnegan, Jr., PhD Dr. Finnegan has nothing to disclose.
Gerald Awele Onwuegbuzie, MD No disclosure on file
Francois Cadiou, MBA Mr. Cadiou has received personal compensation for serving as an employee of Healint.
Lakshmi N. Ranganathan, MD, FAAN Dr. Ranganathan has nothing to disclose.
Anthony Thompson, Other Mr. Thompson has nothing to disclose.
Michael G. Dwyer, III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Jon V. Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Robert B. Darnell, MD, PhD Dr. Darnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atreca, Inc.. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MITRE. Dr. Darnell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for OPNA.
Daniel Mandel, MD Dr. Mandel has nothing to disclose.
Rajit Pahwa Dr. Pahwa has nothing to disclose.
George C. Vilanilam, MD Dr. Vilanilam has nothing to disclose.
Jeroen JG Geurts The institution of Jeroen JG Geurts has received research support from Biogen, Celgene, Merck, Medday, and Novartis.
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Kaiz Shabbar Asif, MD Dr. Asif has nothing to disclose.
Sharon Hassin, MD Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDISON. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NEURODERM. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Hassin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA.
Dana Horakova Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Lovingly Q. Park, PhD Dr. Park has received personal compensation for serving as an employee of Supernus Pharmaceuticals.
Mawj Al-Ani Dr. Al-Ani has nothing to disclose.
Sebastian Paus, MD Prof. Paus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Prof. Paus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Prof. Paus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for abbvie. Prof. Paus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Paus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Prof. Paus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Prof. Paus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
Niels Bergsland Prof. Bergsland has nothing to disclose.
Kristina Brewer Ms. Brewer has nothing to disclose.
Cemal Karakas, MD Dr. Karakas has nothing to disclose.
Hannah Irvine, MD Dr. Irvine has nothing to disclose.
Blair Cotton Blair Cotton has nothing to disclose.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Daniel D. Truong, MD, FAAN The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Erwin Van Wegen, PhD Dr. Van Wegen has nothing to disclose.
Melissa Assaf, NP, APN-Genetics Dr. Assaf has nothing to disclose.
Ashley Schreiber, Other Mr. Schreiber has received personal compensation for serving as an employee of GW Pharmaceuticals. Mr. Schreiber has received stock or an ownership interest from GW Pharmaceuticals.
Gena M. ELassall Dr. ELassall has nothing to disclose.
Dani Stoltzfus, PhD Dr. Stoltzfus has received personal compensation for serving as an employee of NeuBase therapeutics . Dr. Stoltzfus has received stock or an ownership interest from NeuBase therapeutics . Dr. Stoltzfus has received intellectual property interests from a discovery or technology relating to health care.
Kim I. Bishop, PhD Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for zogenix. Dr. Bishop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medtronic. Dr. Bishop has stock in zogenix.
Maya N. Hatch, PhD Maya Hatch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioniks. Maya Hatch has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. The institution of Maya Hatch has received research support from Fulcrum Therapeutics.
Navreet Kaur, MBBS Dr. Kaur has nothing to disclose.
Gabrielle Macaron, MD Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Macaron has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Macaron has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for John Hopkins E-Litterature review. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Macaron has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Macaron has received research support from Biogen Fellowship Grant . The institution of Dr. Macaron has received research support from National MS Society.
Megan Leitch, MD Dr. Leitch has nothing to disclose.
Alex Aimetti, PhD Dr. Aimetti has received personal compensation for serving as an employee of Marinus Pharmaceuticals.
Gregory N. Beatch, PhD Dr. Beatch has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc. Dr. Beatch has stock in Xenon Pharmaceuticals Inc. Dr. Beatch has received intellectual property interests from a discovery or technology relating to health care.
Quentin Funk Quentin Funk has nothing to disclose.
Kathleen Bradbury Ms. Bradbury has nothing to disclose.
Fawaz Al-Mufti, MD Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Peter Alabi, Sr., MBBS, FMCP Dr. Alabi has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Norvatis.
Namita Tundia, PhD Mrs. Tundia has received personal compensation for serving as an employee of EMD Serono.
Constanza Luzon Constanza Luzon has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Constanza Luzon has stock in Xenon Pharmaceuticals.
Deborah I. Friedman, MD, MPH, FAAN Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Satsuma. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . The institution of Dr. Friedman has received research support from Spinal CSF Leak Foundation. Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to AAN interests or activities. Dr. Friedman has a non-compensated relationship as a Treasurer, Board of Directors with Southern Headache Society that is relevant to AAN interests or activities.
Clara Adele Thiel, MD Dr. Thiel has nothing to disclose.
Ali Mohajer, PhD Dr. Mohajer has received personal compensation for serving as an employee of Qral Group, LLC.
John Kent Chin, MD The institution of Dr. Chin has received research support from GE Healthcare.
Krithi Irmady, MBBS, MD An immediate family member of Dr. Irmady has received personal compensation in the range of $0-$499 for serving as a Consultant for Adivo Associates LLC. An immediate family member of Dr. Irmady has stock in Doximity. The institution of Dr. Irmady has received research support from William N and Bernice E Bumpus Foundation. The institution of Dr. Irmady has received research support from American Academy of Neurology. An immediate family member of Dr. Irmady has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Cancer Prevention and Research Institute Texas(CPRIT). Dr. Irmady has received personal compensation in the range of $0-$499 for serving as a Reviewer with Luxembourg National Research fund . An immediate family member of Dr. Irmady has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Memorial Sloan Kettering Cancer Center.
E Martina Bebin, MD Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program.
Eric Klawiter, MD, FAAN Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
MSBase Study Group No disclosure on file
Samar Eldahtoury Mrs. Eldahtoury has nothing to disclose.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
L Matthew Frank, MD Dr. Frank has received stock or an ownership interest from ReAlta Life Sciences.
Kiana Moussavi, MD Ms. Moussavi has nothing to disclose.
Olof Dahlqvist Leinhard Olof Dahlqvist Leinhard has received personal compensation for serving as an employee of AMRA Medical AB. Olof Dahlqvist Leinhard has received stock or an ownership interest from AMRA Medical AB.
Tiffany Ward, MD Dr. Ward has nothing to disclose.
Weijie Poh, PhD Dr. Poh has received personal compensation for serving as an employee of Healint. Dr. Poh has received stock or an ownership interest from PathoVax, LLC.
Mustafa Turkmani, MD Dr. Turkmani has nothing to disclose.
Lucienne Ronco No disclosure on file
Paula Barreras, MD The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from American Academy of Neurology.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Arnold Gammaitoni, PharmD Dr. Gammaitoni has received personal compensation for serving as an employee of Zogenix Inc.. Dr. Gammaitoni has received stock or an ownership interest from Zogenix Inc..
Mohamed Ibrahim Gbreel, Other Dr. Gbreel has nothing to disclose.
Mark A. Hirsch The institution of Mark A. Hirsch has received research support from Amsterdam University Medical Center. The institution of Mark A. Hirsch has received research support from Merz Neurosciences. The institution of Mark A. Hirsch has received research support from Dutch Brain Foundation. The institution of Mark A. Hirsch has received research support from Wake Forest School of Medicine. The institution of Mark A. Hirsch has received research support from NIH. The institution of Mark A. Hirsch has received research support from NIH. Mark A. Hirsch has received personal compensation in the range of $100,000-$499,999 for serving as a Senior Scientist with Atrium Health .
Neil Samuel Nyholm Graham, MD The institution of Dr. Graham has received research support from UK National Institute for Health Research. The institution of Dr. Graham has received research support from Alzheimer's Research UK.
Niall Bourke Niall Bourke has nothing to disclose.
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Acumen. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for AlzPATH. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Annexon. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Apellis. Henrik Zetterberg has received personal compensation in the range of $0-$499 for serving as a Consultant for Fujirebio. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Amanda Heslegrave Amanda Heslegrave has nothing to disclose.
Caryn R. Hale, PhD Dr. Hale has nothing to disclose.
Jose Luis Sanchez Menoyo, MD Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Thomas Samuel Carroll, PhD Dr. Carroll has nothing to disclose.
Rizwana Qadri, PhD Dr. Qadri has nothing to disclose.
Neel * Use352789 Krishna, PhD Dr. Krishna has received personal compensation for serving as an employee of ReAlta Life Sciences. Dr. Krishna has stock in ReAlta Life Sciences. Dr. Krishna has received intellectual property interests from a discovery or technology relating to health care.
Alise Kathryn Carlson, MD Dr. Carlson has received research support from Biogen (fellowship grant 16696-P-FEL).
Max Keeling No disclosure on file
Lindsey Michael Ladd, DO Dr. Ladd has nothing to disclose.
Joseph Hulihan, Jr., MD Dr. Hulihan has received personal compensation for serving as an employee of MARINUS PHARMACEUTICALS. Dr. Hulihan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ZYNERBA PHARMACEUTICALS.
Jaroslaw Slawek, MD No disclosure on file
Krutika Jariwala-Parikh, PhD Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Elisabetta Verdun Di Cantogno, MD Dr. Verdun Di Cantogno has received personal compensation for serving as an employee of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. Dr. Verdun Di Cantogno has stock in EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sukriye Damla Kara, MD Dr. Kara has nothing to disclose.
Jennifer *Use 325910 Shoskes, PharmD Dr. Shoskes has received personal compensation for serving as an employee of Fulcrum Therapeutics. An immediate family member of Dr. Shoskes has received personal compensation for serving as an employee of Exact Science.